newsfilter
← Latest News
Bloomberg·

J&J to Buy Momenta for About $6.5 Billion for Autoimmune Drugs

Johnson & Johnson agreed to buy Momenta Pharmaceuticals Inc. for about $6.5 billion to expand in treatments for autoimmune diseases.